Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment.

Pinto-Medel MJ, Oliver-Martos B, Urbaneja-Romero P, Hurtado-Guerrero I, Ortega-Pinazo J, Serrano-Castro P, Fernández Ó, Leyva L

Open source

DOI
10.1038/s41598-017-09301-2
Published
2017 Aug 18
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-017-09301-2,
  title = {Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment.},
  author = {Pinto-Medel MJ and Oliver-Martos B and Urbaneja-Romero P and Hurtado-Guerrero I and Ortega-Pinazo J and Serrano-Castro P and Fernández Ó and Leyva L},
  year = {2017},
  journal = {Scientific reports},
  doi = {10.1038/s41598-017-09301-2},
  url = {https://doi.org/10.1038/s41598-017-09301-2}
}

RIS

TY  - JOUR
TI  - Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment.
AU  - Pinto-Medel MJ
AU  - Oliver-Martos B
AU  - Urbaneja-Romero P
AU  - Hurtado-Guerrero I
AU  - Ortega-Pinazo J
AU  - Serrano-Castro P
AU  - Fernández Ó
AU  - Leyva L
PY  - 2017
JO  - Scientific reports
DO  - 10.1038/s41598-017-09301-2
UR  - https://doi.org/10.1038/s41598-017-09301-2
ER  - 

APA

MJ, P., B, O., P, U., I, H., J, O., P, S., Ó, F., & L, L. (2017). Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment.. Scientific reports. https://doi.org/10.1038/s41598-017-09301-2

Source records